NEET-PG 2012 Practice Questions

Q: What is the statistical term for the value that occurs most frequently in a data set?

Mode. ***Mode*** - The **mode** is the value that appears most often in a set of data. - It represents the **most frequent observation** within a dataset. *Median* - The **median** is the middle value in a dataset when the values are arranged in ascending or descending order. - It is a measure of **central tendency** that is less affected by outliers than the mean. *Standard deviation* - **Standard deviation** measures the amount of variation or dispersion of a set of values. - A low standard deviation indicates that the data points tend to be **close to the mean**. *Mean* - The **mean** is the arithmetic average of a dataset, obtained by summing all values and dividing by the number of values. - It is a common measure of **central tendency** but can be influenced by extreme values.

Q: 65-year-old person with hearing loss with normal speech discrimination is suffering from?

Presbycusis. ***Presbycusis*** - **Presbycusis**, or age-related hearing loss, is characterized by a gradual, symmetrical, **sensorineural hearing loss** primarily affecting high frequencies. - Importantly, **speech discrimination** is typically preserved in the early and moderate stages of presbycusis, which aligns with the normal speech discrimination in a 65-year-old. *Noise induced hearing loss* - **Noise-induced hearing loss** is caused by exposure to loud noise and often presents with a characteristic **4 kHz notch** in the audiogram. - While it can cause sensorineural hearing loss, it's not exclusively defined by the age-related onset and might involve more significant **speech discrimination difficulties** depending on the severity and frequency range affected. *Ototoxic drug* - Hearing loss due to **ototoxic drugs** (e.g., aminoglycosides, cisplatin) typically manifests as a **bilateral, high-frequency sensorineural hearing loss** that can progress rapidly. - The history of **drug exposure** would be a key differentiating factor, and while speech discrimination can be affected, the lack of other specific details makes this less likely without further information. *NOHL* - **NOHL** is not a standard, recognized medical acronym for a specific type of hearing loss. - This option is likely a distractor and does not represent a known diagnosis fitting the described clinical picture.

Q: What is a characteristic finding in athletes' hearts, also known as athletic syndrome?

Increased amplitude of QRS. ***Increased amplitude of QRS*** - In **athletes' hearts**, the heart muscle (myocardium) undergoes physiological adaptations, including **left ventricular hypertrophy**, which leads to an **increased amplitude of the QRS complex** on an ECG. - This is a normal and beneficial adaptation that enhances cardiac output and efficiency during exercise. *Bradycardia* - While **bradycardia** (a slower heart rate) is very common in athletes due to increased **vagal tone** and improved cardiac efficiency, it is not the most direct characteristic finding *on an ECG* reflecting the structural changes of athletic heart syndrome. - Bradycardia is a rate finding, not a waveform amplitude change reflecting myocardial mass. *Decreased QT interval* - A **decreased QT interval** is not a typical characteristic of an athlete's heart; in fact, there is usually no significant change or a slight prolongation due to bradycardia, but it remains within normal limits. - A pathologically short QT interval can indicate specific genetic channelopathies, which are unrelated to athletic adaptation. *U-waves* - **U-waves** are small positive deflections sometimes seen after the T wave, often associated with **bradycardia** or **hypokalemia**. - While athletes can have bradycardia, U-waves are not a consistent or defining feature of an athlete's heart syndrome itself, and their presence can also indicate other conditions.

Q: Which biomarker is typically elevated in the plasma of patients with chronic heart disease?

B-type natriuretic peptide (BNP). ***B-type natriuretic peptide (BNP)*** - **BNP** is a hormone secreted by **ventricular cardiomyocytes** in response to increased wall stretch and pressure overload, making it a strong indicator of **myocardial stress** and **chronic heart failure** [1]. - Elevated levels correlate with the **severity of heart failure**, aiding in diagnosis and prognosis [1]. *Endothelin-1* - **Endothelin-1** is a potent **vasoconstrictor** involved in vascular tone regulation and endothelial dysfunction. - While it can be elevated in conditions like **pulmonary hypertension** and **atherosclerosis**, it is not a primary diagnostic biomarker for chronic heart disease in general. *Troponin T* - **Troponin T** is a cardiac-specific protein that is released into the bloodstream following **myocardial injury or necrosis**. - While it is a crucial biomarker for **acute coronary syndromes** (e.g., heart attack), persistently elevated levels are not typical for stable chronic heart disease unless there is ongoing subclinical myocardial damage. *Cortisol* - **Cortisol** is a **stress hormone** produced by the adrenal glands, involved in metabolism, immune response, and blood pressure regulation. - While chronic stress can impact cardiovascular health, cortisol itself is not a specific diagnostic biomarker for chronic heart disease.

Q: A person experiences asthma attacks more than twice during the day and at least once during the night. What is the most likely classification of their asthma?

Severe persistent asthma. ***Severe persistent asthma*** - This classification is characterized by **frequent symptoms**, specifically asthma attacks occurring more than twice daily and at least once nightly. - Individuals with severe persistent asthma often experience significant limitations in their daily activities and may have a **FEV1 (forced expiratory volume in 1 second)** less than 60% of predicted. *Intermittent asthma* - This classification is characterized by symptoms occurring less than two days per week and **nighttime awakenings less than two times per month**. - Symptoms are generally well-controlled with a short-acting beta-agonist (SABA) as needed. *Mild persistent asthma* - Patients with mild persistent asthma typically experience symptoms more than twice a week but **less than once a day**, and **nighttime awakenings 3-4 times per month**. - Their lung function (FEV1) is usually 80% or more of predicted. *Moderate persistent asthma* - This category involves daily symptoms and **nighttime awakenings more than once per week but not nightly**. - Lung function (FEV1) in moderate persistent asthma typically falls between 60% and 80% of predicted.

Q: Which of the following is a characteristic of Wilson's disease?

Increased copper in liver. ***Increased copper in liver*** - Wilson's disease is characterized by **accumulation of copper** in liver tissues due to defective copper transport [1]. - This excess leads to **hepatocellular damage**, resulting in liver dysfunction and potential cirrhosis [1]. *Decreased copper excretion in urine* - In Wilson's disease, there is actually **decreased excretion of copper**, which results in accumulation in the liver [1]. - **Urine copper levels** are typically low to normal in early stages because the liver fails to excrete excess copper effectively. *Autosomal dominant* - Wilson's disease is inherited in an **autosomal recessive** pattern, not dominant. - It is caused by mutations in the gene responsible for copper transport (ATP7B) [1]. *Increased serum ceruloplasmin* - Serum ceruloplasmin levels are often **decreased** in Wilson's disease due to impaired copper incorporation into this protein [1]. - Low ceruloplasmin is a key laboratory finding, contrasting the assertion of this option.

Q: Which of the following is the mechanism of action of tetanospasmin ?

Inhibition of release of GABA and glycine. ***Inhibition of release of GABA and glycine*** - **Tetanospasmin** is a potent neurotoxin produced by *Clostridium tetani* that acts by blocking the release of inhibitory neurotransmitters, specifically **GABA (gamma-aminobutyric acid)** and **glycine**, from presynaptic terminals in the spinal cord and brainstem. - This inhibition leads to **uncontrolled muscle spasms**, rigidity, and convulsions, characteristic of tetanus, due to the lack of inhibitory signals to motor neurons. *Inhibition of Ach release from synapse* - This mechanism is characteristic of **botulinum toxin** (produced by *Clostridium botulinum*), not tetanospasmin. - Botulinum toxin inhibits the release of **acetylcholine (ACh)** at the neuromuscular junction, leading to flaccid paralysis. *Inhibition of protein synthesis* - This mechanism is associated with toxins like **diphtheria toxin** and **exotoxin A** from *Pseudomonas aeruginosa*. - These toxins inactivate elongation factor-2 (EF-2), thereby blocking protein synthesis and causing cell death. *Activation of adenylyl cyclase* - Toxins such as **cholera toxin** and **pertussis toxin** act by activating adenylyl cyclase, leading to an increase in intracellular cAMP levels. - This mechanism causes effects like severe diarrhea in cholera and respiratory symptoms in whooping cough.

Q: Which of the following is a renal-specific nephropathy associated with HIV?

Focal Segmental Glomerulosclerosis (FSGS). ### Focal Segmental Glomerulosclerosis - It is a common renal complication associated with **HIV infection**, characterized by **podocyte injury** and segmental sclerosis [1]. - Often results in **nephrotic syndrome**, presenting with significant **proteinuria** and edema, making it distinct in HIV renal pathology [1]. ### Membranous Glomerulonephritis - Typically presents with **subepithelial immune complex deposits**, leading to a different pathophysiological mechanism. - More commonly associated with other secondary causes, such as **drugs** or **infection**, rather than being specific to HIV. ### Mesangioproliferative Glomerulonephritis - Characterized by **mesangial cell proliferation and immune complex deposition**, often linked with various infections but not specifically with HIV. - Usually shows **hematuria** and mild proteinuria, lacking the severe nephrotic syndrome seen in focal segmental glomerulosclerosis. ### Membranoproliferative Glomerulonephritis - Features **proliferation of mesangial and endothelial cells**, leading to a distinctive pattern on renal biopsy, not specific to HIV. - Typically presents in other contexts such as **chronic infections** or **autoimmune diseases**, rather than predominantly with HIV.

Q: What is the primary therapeutic use of 5-HT1B/1D agonists?

Acute migraine treatment. ***Acute migraine treatment*** - 5-HT1B/1D agonists, such as **triptans**, primarily work by causing **vasoconstriction of intracranial blood vessels** and inhibiting the release of pro-inflammatory neuropeptides. - This action directly alleviates the pain and associated symptoms of **acute migraine attacks**. *Anti-anxiety medications* - Anti-anxiety medications typically target neurotransmitter systems like **GABA** (e.g., benzodiazepines) or **serotonin reuptake** (e.g., SSRIs), not the 5-HT1B/1D receptors in this context. - While serotonin plays a role in anxiety, specific 5-HT1B/1D agonism does not lead to anxiolytic effects. *Anti-nausea medications for chemotherapy* - Anti-nausea medications used for chemotherapy-induced nausea and vomiting often target **5-HT3 receptors** (e.g., ondansetron) to block their pro-emetic effects. - 5-HT1B/1D agonists do not have primary anti-emetic properties useful in this setting. *Drugs for gastroesophageal reflux disease (GERD)* - GERD medications primarily focus on reducing stomach acid production (e.g., **proton pump inhibitors**, H2 blockers) or neutralizing it (antacids). - 5-HT1B/1D agonists do not directly influence gastric acid secretion or esophageal motility in a way beneficial for GERD.

Q: All of the following occurs because of prostaglandin use except?

Excess water retention. ***Excess water retention*** - **Prostaglandins** generally promote **diuresis** and natriuresis, meaning they help the body excrete water and sodium, rather than retain them [2]. - While some prostaglandins can affect renal blood flow, direct causation of **excess water retention** as a primary side effect is not typical. *Flushes* - **Prostaglandins**, particularly **PGE1** and **PGE2**, are potent **vasodilators** and can cause cutaneous vasodilation, leading to **flushing** and a sensation of warmth [3]. - This effect is often mediated by the relaxation of vascular smooth muscle. *Increased motility of bowel* - Many **prostaglandins**, especially **PGE** and **PGF** series, stimulate **smooth muscle contraction**, including in the gastrointestinal tract [1]. - This increased contraction can lead to **enhanced bowel motility**, sometimes causing diarrhea or abdominal cramping [1]. *Nausea* - **Prostaglandins** can have various systemic effects, and activation of pathways in the central nervous system or direct irritation of the GI tract can lead to symptoms like **nausea** and vomiting [1]. - This is a common side effect, especially with systemic administration.

Question 1

What is the statistical term for the value that occurs most frequently in a data set?

Accepted Answer

Mode

Answer

Median

Answer

Standard deviation

Answer

Mean

Question 2

65-year-old person with hearing loss with normal speech discrimination is suffering from?

Accepted Answer

Presbycusis

Answer

Noise induced hearing loss

Answer

Ototoxic drug

Answer

NOHL

Question 3

What is a characteristic finding in athletes' hearts, also known as athletic syndrome?

Accepted Answer

Increased amplitude of QRS

Answer

Decreased QT interval

Answer

U-waves

Answer

Bradycardia

Question 4

Which biomarker is typically elevated in the plasma of patients with chronic heart disease?

Accepted Answer

B-type natriuretic peptide (BNP)

Answer

Endothelin-1

Answer

Troponin T

Answer

Cortisol

Question 5

A person experiences asthma attacks more than twice during the day and at least once during the night. What is the most likely classification of their asthma?

Accepted Answer

Severe persistent asthma

Answer

Intermittent asthma

Answer

Mild persistent asthma

Answer

Moderate persistent asthma

Question 6

Which of the following is a characteristic of Wilson's disease?

Accepted Answer

Increased copper in liver

Answer

Autosomal dominant

Answer

Increased serum ceruloplasmin

Answer

Decreased copper excretion in urine

Question 7

Which of the following is the mechanism of action of tetanospasmin ?

Accepted Answer

Inhibition of release of GABA and glycine

Answer

Inhibition of Ach release from synapse

Answer

Inhibition of protein synthesis

Answer

Activation of adenylyl cyclase

Question 8

Which of the following is a renal-specific nephropathy associated with HIV?

Accepted Answer

Focal Segmental Glomerulosclerosis (FSGS)

Answer

Mesangioproliferative Glomerulonephritis

Answer

Membranous Nephropathy

Answer

Membranoproliferative Glomerulonephritis (MPGN)

Question 9

What is the primary therapeutic use of 5-HT1B/1D agonists?

Accepted Answer

Acute migraine treatment

Answer

Anti-anxiety medications

Answer

Anti-nausea medications for chemotherapy

Answer

Drugs for gastroesophageal reflux disease (GERD)

Question 10

All of the following occurs because of prostaglandin use except?

Accepted Answer

Excess water retention

Answer

Increased motility of bowel

Answer

Nausea

Answer

Flushes

NEET-PG 2012

Community Medicine

ENT

Internal Medicine

Microbiology

Pathology

Pharmacology